Literature DB >> 22831872

Generic health-related quality of life is significantly worse in varicose vein patients with lower limb symptoms independent of CEAP clinical grade.

K A L Darvall1, G R Bate, D J Adam, A W Bradbury.   

Abstract

OBJECTIVES: To determine the relationship between lower limb symptoms and generic health-related quality of life (HRQL) in patients with varicose veins (VV).
METHODS: 284 patients on the waiting list for VV treatment completed the Short Form-12 (SF12) and a questionnaire asking about the presence of lower limb symptoms commonly attributed to venous disease (pain or ache, itching, tingling, cramp, restless legs, a feeling of swelling, and heaviness).
RESULTS: Median age was 57 years (interquartile range 45-67); 100 (35%) were male, and 182 (64%) had CEAP clinical grade 2 or 3 disease. Jonckheere-Terpstra test for trend revealed that both physical (P < .0005) and mental (P = .001) HRQL worsened as the reported number of symptoms increased. Patients reporting tingling (P = .016, Mann-Whitney U test), cramp (P = .001), restless legs (P < .0005), swelling (P < .0005), and heaviness (P < .0005) had a significantly worse physical HRQL than those who did not. Mental HRQL was also significantly worse in patients with tingling (P = .010), cramp (P = .008), restless legs (P = .040), swelling (P = .001), and heaviness (P = .035). These significant relationships remained, and pain was also correlated with worse physical HRQL (P = .011), when linear regression was performed to control for CEAP clinical grade, age and sex.
CONCLUSIONS: Physical and mental HRQL is significantly worse in VV patients with lower limb symptoms irrespective of the clinical stage of disease. This observation confirms that VV are not primarily a cosmetic problem and that NHS rationing of treatment to those with CEAP C4-6 disease excludes many patients who would benefit from intervention in terms of HRQL. Generic HRQL instruments also allow comparison with interventions for other chronic conditions.
Copyright © 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22831872     DOI: 10.1016/j.ejvs.2012.06.022

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

1.  Reliability and Validity of the MD Anderson Dysphagia Inventory Among Japanese Patients.

Authors:  Yuhei Matsuda; Manabu Kanazawa; Yuriko Komagamine; Masashi Yamashiro; Sumio Akifusa; Shunsuke Minakuchi
Journal:  Dysphagia       Date:  2017-08-24       Impact factor: 3.438

2.  Treatment Patterns and Outcomes in Patients with Varicose Veins.

Authors:  Rajiv Mallick; Aditya Raju; Chelsey Campbell; Rashad Carlton; David Wright; Kimberly Boswell; Michael Eaddy
Journal:  Am Health Drug Benefits       Date:  2016-11

3.  Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.

Authors:  David D I Wright; Jean Paty; Diane M Turner-Bowker; Andrew Bradbury
Journal:  Patient       Date:  2016-08       Impact factor: 3.883

4.  Compliance with NICE guidelines when commissioning varicose vein procedures.

Authors:  D Carradice; J Forsyth; A Mohammed; C Leung; L Hitchman; A E Harwood; T Wallace; G E Smith; B Campbell; I Chetter
Journal:  BJS Open       Date:  2018-08-29

5.  The effect of compression therapy on quality of life in patients with chronic venous disease: a comparative 6-month study.

Authors:  Andrzej Berszakiewicz; Janusz Kasperczyk; Aleksander Sieroń; Zbigniew Krasiński; Armand Cholewka; Agata Stanek
Journal:  Postepy Dermatol Alergol       Date:  2020-01-31       Impact factor: 1.837

6.  Nonthermal Endovenous Procedures for Varicose Veins: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04

7.  Varicose veins and its risk factors among nurses at Dhulikhel hospital: a cross sectional study.

Authors:  Regan Shakya; Robin Man Karmacharya; Rojina Shrestha; Archana Shrestha
Journal:  BMC Nurs       Date:  2020-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.